Wells Fargo’s Insmed INSM Stock Holding History

Wells Fargo’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-56,500	Closed	-$43K	–	6475
2019 Q4	$43K	Hold	56,500	–	–	﹤0.01%	5556
2019 Q3	$296K	Hold	56,500	–	–	﹤0.01%	4732
2019 Q2	$138K	Buy	+56,500	New	+$1.57M	﹤0.01%	5161
2019 Q1	–	Sell	-106,500	Closed	-$922K	–	6240
2018 Q4	$922K	Buy	+106,500	New	+$1.7M	﹤0.01%	3896

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Wells Fargo's INSM Position: Q2 2026 in Review

Wells Fargo reduced its Insmed (INSM) stake by 57% in Q2 2026, selling an estimated $40.9M and leaving 259,852 shares worth $27.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

Wells Fargo first reported a position in INSM in Q4 2013 and has held it in 51 quarters since. The position peaked at $102M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Wells Fargo held 259,852 shares of Insmed worth $27.7M as of Q2 2026.
Wells Fargo sold 337,532 Insmed shares in Q2 2026, an estimated $40.9M.
Insmed made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1397 holding.
Wells Fargo first reported a position in Insmed in Q4 2013 and has held it in 51 quarters since.
Wells Fargo's Insmed position peaked at $102M in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.